Stocksigma LogoStocksigma Logo

Corona Remedies Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

■ Revenue: 441 (+22.2% YoY | +4.4% QoQ) ■ EBITDA: 96.0 (+22.3% YoY | +3.0% QoQ) ■ EBITDA Margin (%): 21.7 (+2 bps YoY | -30 bps QoQ) ■ PAT: 60.3 (+15.3%

Corona Remedies Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

Corona Remedies Ltd · Outcome · 30 Oct 2026, 11:58 pm

Corona Remedies Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 441 (+22.2% YoY | +4.4% QoQ) ■ EBITDA: 96.0 (+22.3% YoY | +3.0% QoQ) ■ EBITDA Margin (%): 21.7 (+2 bps YoY | -30 bps QoQ) ■ PAT: 60.3 (+15.3% YoY | +0.3% QoQ) ■ EPS (INR): 9.86 (+15.3% YoY | +0.3% QoQ)

Original exchange filing (PDF)

More announcements from Corona Remedies Ltd

All Corona Remedies Ltd announcements